OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $403,262.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 16,300 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $24.74, for a total transaction of $403,262.00. Following the sale, the insider directly owned 6,881,464 shares in the company, valued at $170,247,419.36. The trade was a 0.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Trading Down 1.9%

Shares of KIDS stock traded down $0.47 during trading hours on Wednesday, hitting $24.03. 169,608 shares of the company’s stock traded hands, compared to its average volume of 171,545. The stock has a market cap of $627.42 million, a PE ratio of -14.30 and a beta of 0.98. The stock’s 50 day simple moving average is $21.11 and its 200 day simple moving average is $18.53. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on KIDS. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Weiss Ratings raised OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Piper Sandler reiterated an “overweight” rating and issued a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Truist Financial set a $22.00 target price on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Needham & Company LLC raised their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $26.44.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Russell Investments Group Ltd. grew its stake in OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares during the period. Legal & General Group Plc bought a new stake in shares of OrthoPediatrics in the 2nd quarter valued at $34,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of OrthoPediatrics by 5,226.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after acquiring an additional 2,561 shares during the period. Caption Management LLC bought a new position in OrthoPediatrics during the third quarter worth $54,000. Finally, BNP Paribas Financial Markets boosted its stake in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after acquiring an additional 1,235 shares in the last quarter. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.